Document is current
Any future updates will be listed below
-
Authors
Yuan, Guangwen
Lou, Ge
Li, Jundong
Xu, Mei https://orcid.org/0009-0005-2372-7530
Liu, Xiaowei
Wang, Danbo
Zhang, Keqiang
Zhu, Tao https://orcid.org/0000-0003-0718-4941
Li, Xiumin
Huang, Yi
Duan, Wei
Wang, Ke
Zhou, Qi https://orcid.org/0000-0001-5673-4263
Li, Guiling
Yang, Chen https://orcid.org/0009-0006-1943-3377
Zhang, Jiajing
Sun, Haolin
Tang, Renhong
Li, Qingshui https://orcid.org/0009-0006-9812-2322
Wu, Lingying https://orcid.org/0000-0003-3153-7786
-
Funding
Funding for this research was provided by:
This trial was sponsored by Simcere Zaiming Pharmaceuticals Co. Ltd.
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 30 October 2025
First Online: 9 January 2026
Competing interests
: Simcere Zaiming Pharmaceuticals Co., Ltd., the sponsor of this trial, covered all trial costs, including investigational drugs, laboratory tests and associated operational cost. C.Y., J.Z., H.S. and R.T. are full-time employees of Simcere Zaiming Pharmaceuticals Co., Ltd. The other authors declare no competing interests.
